Hypertension, Vol 8, 399-406, Copyright © 1986 by American Heart Association
RM Carey and CR Drake Jr
Previous studies have suggested that dopamine may have an important role as
an inhibitor of aldosterone secretion in humans. Recent studies have also
suggested that the adrenergic nervous system may have an important role in
controlling aldosterone secretion. The present study investigated the
effects of dopamine on aldosterone secretion in response to angiotensin II,
with and without pretreatment with propranolol, and to adrenocorticotropic
hormone, another known stimulator of aldosterone secretion. Nine normal
subjects in balance at 10 mEq sodium intake received dopamine (4
micrograms/kg/min) or vehicle for 270 minutes on 2 consecutive days on
three separate occasions. After 120 minutes of dopamine infusion, the
subjects received a 30- minute intravenous infusion of angiotensin II (in
cumulative doses of 0.5, 1, 2, 4, and 6 pmol/kg/min), angiotensin II after
oral pretreatment with propranolol, or adrenocorticotropic hormone (in
cumulative doses of 0.5, 1, 2, and 5 U/hr). Aldosterone responses to 2, 4,
and 6 pmol/kg/min of angiotensin II (without propranolol) were greater in
vehicle-treated than in dopamine-treated subjects (p less than 0.05), as
was the slope of the angiotensin II-vehicle dose- response curve (0.46, p
less than 0.05). Propranolol suppressed the aldosterone response to
angiotensin II, but dopamine still inhibited the response. Aldosterone and
cortisol secretion were stimulated equally by adrenocorticotropic hormone
in dopamine-treated and vehicle- treated groups. These results suggest that
dopamine selectively inhibits the aldosterone response to angiotensin II
and that this response is not mediated by teh activity of dopamine at
beta-adrenergic receptors.
ARTICLES
Dopamine selectively inhibits aldosterone responses to angiotensin II in humans
This article has been cited by other articles:
![]() |
C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON Dopamine Receptors: From Structure to Function Physiol Rev, January 1, 1998; 78(1): 189 - 225. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |